MARCKS Regulates Growth and Radiation Sensitivity and Is a Novel Prognostic Factor for Glioma

1 Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study The Lancet Oncology, April 24, 2013

2 Mobile phone use and risk of brain neoplasms and other cancers: prospective study International Journal of Epidemiology, May 10, 2013

3 Patterns of exposure to infectious diseases and social contacts in early life and risk of brain tumours in children and adolescents: an International Case-Control Study (CEFALO) British Journal of Cancer, May 10, 2013

4 Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study The Lancet Oncology, May 3, 2013

5 Phase I study of temozolomide combined with oral etoposide in children with malignant glial tumors Journal of Neuro-Oncology, May 20, 2013

6 Phase I trial, pharmacokinetics, and pharmacodynamics of vandetanib and dasatinib in children with newly diagnosed diffuse intrinsic pontine glioma Clinical Cancer Research, May 14, 2013

7 Intensity-modulated radiotherapy (IMRT) in pediatric low-grade glioma Cancer, May 3, 2013

8 Descriptive epidemiology of ependymal tumours in the United States British Journal of Cancer, May 10, 2013

9 Combined temozolomide and sunitinib treatment leads to better tumour control but increased vascular resistance in O6-methylguanine methyltransferase-methylated gliomas European Journal of Cancer, April 29, 2013

10 Autologous Tumor Lysate-pulsed Dendritic Cell Immunotherapy for Pediatric Patients with Newly Diagnosed or Recurrent High-grade Gliomas Anticancer Research, May 9, 2013